Can You Take Spravato at Home? What to Know

Spravato cannot be taken at home. Every dose has to be administered inside a certified healthcare setting under the SPRAVATO REMS program, the FDA’s Risk Evaluation and Mitigation Strategy created specifically for this drug. That restriction is not a matter of clinic preference. It’s a federal requirement tied directly to how esketamine, the active ingredient in Spravato, affects the body.

Two facts explain why. First, esketamine can cause sedation, dissociation, and in rare cases, respiratory depression, effects serious enough that clinicians need to watch you in real time. Second, the prescribing information requires you to stay under observation for a set period after your dose, something no home environment can replicate safely.

Here’s what that means in practice for anyone considering Spravato treatment at home:

• You must receive every dose at a REMS-certified clinic or hospital, never at your house.
• You’ll be observed for roughly two hours after administration before a clinician clears you to leave.
• You cannot drive yourself home. You need a driver or another safe way to get there.
• You cannot self-administer the drug and take it with you between appointments.

Key Takeaways

Spravato must be administered under direct clinical supervision at a REMS-certified site because its sedative and dissociative effects require real-time safety monitoring that no home setting can provide.

Table of Contents

• What Does a Spravato at Home Alternative Actually Look Like in the Clinic?
• Why Can’t Spravato Be Given at Home?
• Who Qualifies for Spravato, and Who Doesn’t?
• Preparing for a Spravato Session and What Happens After
• How Do You Actually Get Access to Spravato?
• If Spravato Isn’t Right for You, What Are the Alternatives?
• What Clinicians Want You to Know About Spravato
• How Imindmental Can Help You Start Spravato Treatment
• Sources

What Does a Spravato at Home Alternative Actually Look Like in the Clinic?

If you’re picturing a scenario where you could someday do this on your own couch, it helps to understand what “supervised self-administration” actually means. You do administer the nasal spray yourself, spraying it into each nostril following your clinician’s instructions, but a trained provider stays in the room to guide the process and watch for reactions the entire time.

The dosing itself follows a fixed structure. Each device delivers 28 mg of esketamine, so a 56 mg dose uses two devices and an 84 mg dose uses three. Clinicians build in a five-minute rest between each device to let your nasal tissue absorb the medication properly before moving to the next spray.

Pro Tip: Ask your clinic whether they schedule Spravato sessions earlier in the day. Many patients feel groggy for a few hours afterward, and morning appointments leave more of the day to recover before needing to function normally again.

A typical session moves through a few predictable stages:

1. Check-in and baseline vital signs, including blood pressure, which can rise temporarily after dosing.
2. Nasal preparation, sometimes including a decongestant if your provider recommends it.
3. Administration under direct clinician supervision.
4. Observation checks at set intervals, often around 20, 40, 90, and 120 minutes post-dose.
5. A discharge assessment where the treating provider, not you, decides when you’re clear to leave.

During that window, you may notice dizziness, a floating or detached feeling (dissociation), nausea, or a temporary rise in blood pressure. Most of these effects fade within the two-hour monitoring period, which is precisely why that window exists.

Why Can’t Spravato Be Given at Home?

The REMS program isn’t bureaucratic caution for its own sake. The FDA created REMS requirements for drugs whose risk profile demands restricted distribution and active safety monitoring, and Spravato qualifies on several fronts: sedation, dissociation, elevated blood pressure, respiratory depression, and a recognized potential for misuse given esketamine’s relationship to ketamine.

Clinic-based monitoring exists to catch these risks before they become emergencies. Providers track your vitals at intervals, keep oxygen and emergency equipment on hand, and make a clinical judgment call about your readiness to leave rather than letting a timer decide. That combination of real-time vitals, clinician judgment, and equipment access is exactly what a home setting cannot provide, no matter how comfortable or well-intentioned.

From a regulatory standpoint, the consequence is straightforward: Spravato is dispensed only through certified pharmacies directly to certified treatment centers. It never goes home with you, and no prescription lets you take doses outside a monitored setting. This is one of the few current depression treatments where the how of delivery is as tightly controlled as the drug itself.

Pro Tip: If the twice-weekly or weekly visit schedule feels hard to manage around work or caregiving, say so during your intake evaluation. Many clinics offer early-morning or evening slots specifically to make repeated visits more workable, and transportation logistics are worth solving before treatment starts, not after your first session.

Who Qualifies for Spravato, and Who Doesn’t?

Spravato is FDA-approved for treatment-resistant depression in adults, generally defined as depression that hasn’t responded to at least two different oral antidepressants at adequate doses, and for major depressive disorder with acute suicidal ideation or behavior. In nearly every case, Spravato is prescribed alongside an oral antidepressant rather than as a standalone treatment.

Eligibility, though, is only half the picture. A number of medical conditions can disqualify you from treatment, and your prescriber will screen for these carefully before approval:

• Aneurysmal vascular disease or a history of intracerebral hemorrhage
• Uncontrolled or poorly managed seizure disorders
• Severe hepatic impairment, classified as Child-Pugh class C
• Interstitial cystitis or ulcerative cystitis
• Pregnancy or breastfeeding
• Active psychosis or certain bipolar disorder presentations

Getting approved usually means your clinician documents which antidepressants you’ve already tried, at what doses, and for how long they failed to help. Many prescribers also use standardized symptom scales, such as PHQ-9 scores, to establish a clear baseline of severity that insurers can review during prior authorization.

Preparing for a Spravato Session and What Happens After

Good preparation makes the actual session smoother, and most of it is simple logistics rather than anything medically complicated.

Before your appointment, plan around these guidelines:

• Avoid food for at least two hours before dosing and liquids for 30 minutes beforehand, since nausea is a known side effect and an empty stomach helps.
• If you use nasal corticosteroids or decongestants, time them at least an hour before treatment.
• Bring your ID and current insurance information to each visit.
• Arrange a driver in advance. You will not be cleared to drive yourself home.

Once you’re in the treatment room, follow your clinician’s self-administration instructions closely and expect the monitoring checkpoints mentioned earlier. Afterward, the rules are just as firm as the ones beforehand: no driving, no operating machinery, and no major decisions for the rest of the day. Plan for a quiet evening and a ride home you’ve already lined up.

Pro Tip: Bring headphones or a comforting playlist. Many patients find that something familiar to listen to during the dissociative phase makes the experience feel less disorienting, and clinics generally welcome small comfort items like this.

How Do You Actually Get Access to Spravato?

Finding treatment starts with locating a REMS-certified clinic, since Spravato cannot be prescribed or dispensed anywhere else. Once you’ve identified one, both you and the prescribing provider complete REMS enrollment, a straightforward administrative step that confirms the safety protocols will be followed.

From there, prior authorization is usually the longest part of the process. Insurers typically want documentation of failed antidepressant trials, current symptom severity scores, and a clinician’s written rationale for why Spravato is appropriate for you specifically. Bringing your own treatment history and prior prescription records to your first evaluation can shave real time off this step.

For veterans, the pathway runs somewhat differently. The VA treats intranasal esketamine as medically necessary only with documented failed trials, and access is often routed through community care or interventional psychiatry programs. Spravato also sits as a non-formulary medication within the VA system, which means requests require additional approval steps compared to a standard prescription.

Cost varies depending on your coverage and where you’re treated, but it generally breaks into two pieces: the clinic’s procedure and monitoring fee, and the medication charge itself.

Pro Tip: Ask your clinic’s front desk about manufacturer savings programs before your first visit. Many patients qualify for assistance that meaningfully lowers out-of-pocket costs, but you often have to ask directly since it isn’t always offered upfront.

If Spravato Isn’t Right for You, What Are the Alternatives?

Not everyone qualifies for Spravato, and not everyone who qualifies wants it. If a contraindication rules it out, access proves too difficult, or you simply prefer a different route, several evidence-based options remain worth discussing with your prescriber.

• Oral antidepressants: SSRIs, SNRIs, and other classes remain the first-line treatment for most people and are worth fully exploring, alongside dose adjustments, before moving to more intensive options.
• IV or intramuscular ketamine: Administered under medical supervision, this shares mechanisms with esketamine but follows a different delivery and monitoring protocol.
• Transcranial magnetic stimulation (TMS): A non-drug option that uses magnetic pulses to stimulate targeted brain regions, often considered when medications alone haven’t worked. You can compare brain stimulation therapies to see how TMS stacks up against other approaches.
• Evidence-based psychotherapy: Cognitive behavioral therapy and related approaches, often combined with medication management rather than used as a standalone substitute for severe treatment-resistant cases.
• Integrated care plans: Combining medication, therapy, and lifestyle support tends to outperform any single intervention alone for many patients.

If you’re weighing these options, a short checklist can help you move forward without losing momentum:

1. Talk to your prescriber honestly about contraindications, access barriers, or personal hesitations around Spravato.
2. Request copies of your treatment records and past antidepressant trial history to speed up prior authorization for whichever path you choose.
3. Look into REMS-certified clinics near you if Spravato remains on the table.
4. Ask specifically about patient assistance programs, since cost concerns shouldn’t be the reason you delay care.

What Clinicians Want You to Know About Spravato

Patients almost always ask the same two questions during a first Spravato consultation: how uncomfortable will this be, and why can’t I just do this at home once I know how it works? Those questions make sense. Repeated clinic visits are a real burden, especially for someone already managing depression severe enough to consider Spravato in the first place.

Clinicians hear that concern and take it seriously, but the priority never shifts. Safety monitoring, careful documentation of your response to each dose, and shared decision-making about your treatment plan matter more than convenience, because the risks Spravato carries are real and time-sensitive rather than theoretical. The in-clinic structure exists as a clinical safeguard, not an inconvenience layered on top of treatment.

What tends to surprise patients is how much clinics can flex around the parts that are flexible. Appointment timing, comfort measures during the session, and how your care team coordinates with your therapist or primary prescriber are all open to discussion. If scheduling around work, childcare, or transportation feels like the real obstacle, raise it directly with your clinician. There’s usually more room to work with than people expect.

How Imindmental Can Help You Start Spravato Treatment

If you’ve read this far and Spravato still sounds like the right next step, iMind Mental Health Solutions offers Spravato treatment at certified locations in Port St. Lucie, Vero Beach, and Stuart, FL, with a team that handles the parts of this process that tend to feel overwhelming on your own. That includes verifying your insurance, gathering documentation for prior authorization, and walking you through your treatment history so nothing gets missed in the approval process.

Your first contact typically involves an insurance check and a clinical evaluation to confirm Spravato fits your situation and history. If it doesn’t, or if you’re not sure yet, iMind also offers psychiatry and medication management to help you explore what’s right before committing to a specific treatment path.

To get started, reach out and have your current medication list, prior antidepressant trials, and insurance information ready. That single step often determines how quickly you move from evaluation to your first scheduled session.

Sources

For dosing specifics and device instructions, the SPRAVATO dosage and administration guide from JnJ Medical Connect lays out device counts and rest intervals in detail. For the regulatory framework behind why home use isn’t permitted, the FDA’s REMS overview explains how restricted distribution programs work across drug categories.

Anyone reviewing the full clinical label, including contraindications and monitoring instructions, should consult the official FDA prescribing information. Veterans and their families researching coverage pathways will find the VA’s clinical determinations on intranasal esketamine useful for understanding documentation requirements. If you or someone you know needs immediate behavioral health support while navigating access delays, the SAMHSA national helpline connects callers to local resources at any hour.

This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.

• Risk Evaluation and Mitigation Strategies (REMS) – FDA
• Intranasal Esketamine clinical determinations and indications — U.S. Department of Veterans Affairs

Recommended

• Spravato® in Port St. Lucie: What to Know Before You Start – iMind Mental Health Solutions
• Spravato treatment in Stuart, FL: what to expect – iMind Mental Health Solutions
• spravato treatment – iMind Mental Health Solutions
• Spravato Success Rate: What the Evidence Shows